Manolete Partners (MANO) Share Price, News & Analysis

Company Overview

Manolete Partners Plc is the UK’s leading insolvency litigation financing company which was founded in 2009 by its Chief Executive, Steven Cooklin, a UK Chartered Accountant. Manolete finances the pursuit of claims through litigation and alternative dispute resolution to produce optimal returns for the creditors of insolvent companies. The Company has invested in over 1,300 specialist UK insolvency cases and has recovered over £120m for Creditor Estates with an average case duration of just 12 months per case. Case values range from £20k to over £70m. HSBC provides Manolete with a £17.5m revolving credit facility - Manolete floated on the London Stock Exchange (AIM) in 2018. For three years in succession, the Company has been named as the only firm in the insolvency litigation funding sector to be ranked in Band 1 of the legal industry’s prestigious Chambers Guide.

Key Stats

• Today's Range: 85 to 87.25
• 50-Day Range: 85.50 to 117
• 52-Week Range: 70.14 to 119.30
• Volume: 47,752 shs
• Average Volume: 77,747 shs
• Market Capitalization: £38.23 million
• P/E Ratio: 43.41
• Dividend Yield: 0.37%
• Price Target: GBX 172
• Consensus Rating: Buy

MANO Stock Analysis - Frequently Asked Questions

How have MANO shares performed this year?

Manolete Partners' stock was trading at GBX 88 at the beginning of 2025. Since then, MANO stock has decreased by 0.9% and is now trading at GBX 87.25.

How were Manolete Partners' earnings last quarter?

Manolete Partners Plc (LON:MANO) posted its quarterly earnings results on Thursday, June, 26th. The company reported $2.04 EPS for the quarter. Manolete Partners had a trailing twelve-month return on equity of 109.76% and a net margin of 180.12%.

How do I buy shares of Manolete Partners?

Shares of MANO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Manolete Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Manolete Partners investors own include Advanced Oncotherapy (AVO), IQE (IQE), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR) and Greencore Group (GNC).

Company Calendar

• Last Earnings: 6/26/2025
• Today: 10/25/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Industrials
• Industry: Consulting Services
• Sub-Industry: N/A
• Current Symbol: LON:MANO
• CIK: N/A
• Web: www.manolete-partners.com
• Phone: 44 2038 593 490
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Manolete Partners: GBX 172
• High Price Target: GBX 172
• Low Price Target: GBX 172
• Potential Upside/Downside: +97.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 2.01
• Trailing P/E Ratio: 43.41
• Forward P/E Ratio: 20.36
• P/E Growth: N/A
• Net Income: £40.35 million
• Net Margins: 180.12%
• Pretax Margin: N/A
• Return on Equity: 109.76%
• Return on Assets: 2.33%

Debt

• Debt-to-Equity Ratio: 33.92
• Current Ratio: 4.92
• Quick Ratio: 6.25

Sales & Book Value

• Annual Sales: £30.48 million
• Price / Sales: 1.25
• Cash Flow: GBX 17.22 per share
• Price / Cash Flow: 5.07
• Book Value: GBX 90.92 per share
• Price / Book: 0.96

Miscellaneous

• Outstanding Shares: 43,811,000
• Free Float: N/A
• Market Cap: £38.23 million
• Optionable: Not Optionable
• Beta: 0.77